4//SEC Filing
Dummer Wolfgang 4
Accession 0001140361-23-003443
CIK 0001034842other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 9:45 PM ET
Size
5.5 KB
Accession
0001140361-23-003443
Insider Transaction Report
Form 4
Dummer Wolfgang
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-01-26+50,000→ 100,000 totalExercise: $2.42Exp: 2032-01-24→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The Reporting Person was granted an option with a performance-based condition with respect to 50,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On January 26, 2023, it was determined that the performance metric had been met.
- [F2]The option was fully vested on January 26, 2023, the date the determination was made that the performance metric had been met.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeother
Related Parties
1- filerCIK 0001749991
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 9:45 PM ET
- Size
- 5.5 KB